BioCentury
ARTICLE | Company News

UroCor, Bioniche urology deal

March 7, 2001 8:00 AM UTC

Bioniche (TSE:BNC) granted UCOR exclusive U.S. distribution rights to its Cystistat hyaluronic acid derivative for cystitis, in exchange for a $750,000 upfront fee and up to $2.3 million in milestone ...